Feeling lost?
Why not try these options:
  • Search
  • Browse
or
Call us on

OTC Painkillers - Europe - June 2011

OTC Painkillers - Europe - June 2011

This report looks at the OTC painkiillers market in Europe and provides a unique insight into the current market size and market share, in addition to providing a forecast of the market over the coming years. It also identifies weaknesses and opportunities in the market.

Some of the factors discussed include:

  • During 2005-10, Germany has experienced the greatest decline in value sales of OTC analgesics. Sales have been suffering as German consumers are the least likely to take OTC medication when suffering from ailments, with almost two thirds preferring to wait for symptoms to go on their own.
  • In the UK, the market for OTC analgesics grew by 10% in current terms (0.3% in real value terms, excluding inflation) between 2006-10 to reach an estimated £617 million. However in the three years to 2010, the market has actually slowed in real terms, with value sales declining by 4%.
  • Europe accounted for just under a quarter of global analgesics new product launches during January 2010 to May 2011 (with Mintel GNPD recording 190 new products). The UK led for NPD within the ‘Big 5’ European countries.
  • With a focus on topical rather than ingested products, botanical/ herbal ingredients that can be applied at the point of pain are becoming more widely available. Some of the ingredients that are being developed into pain relief products include ginger, rosemary, white willow, capsicum, and devil’s claw.

£1,999.01

Analgesics

The OTC analgesics market is defined as including all analgesics available over the counter (OTC) without a prescription. This includes topical analgesics (pain relief gels, creams and sprays), alongside oral analgesics, oral lesions and toothache remedies.

OTC pharmaceuticals

The following are the definitions for the OTC pharmaceuticals market for each of the countries under review in this report:

France: Respiratory, digestive, analgesic, dermatological, circulatory, sedatives, vitamins, mouth, eyes, various treatments and other pharmaceuticals sold over-the-counter.

Germany: Cold and throat remedies, analgesics, digestive remedies, dietary supplements, medicated skincare, cardiovascular system, eye care, genito - urinary system & sex hormones and other over the counter medicines.

Italy: Cough & cold remedies, analgesics, digestives, skin products, vitamins & minerals and others.

Spain: Cough & cold, analgesics, digestives, skin products, vitamins & minerals and other OTC pharmaceuticals.

GB: Analgesics, cough & cold remedies, skin treatments, vitamins & minerals, digestive remedies, allergy remedies and smoking cessation treatments.

Austria: Cough & cold, analgesics, digestives, skin products, vitamins & minerals.

Introduction


Key points


Definition


Analgesics

OTC pharmaceuticals

Consumer research


Abbreviations


Executive Summary


The Market


Figure 1: Value sales of OTC analgesics, Big 5, 2005-15

Companies, Brands and Innovation


Figure 2: New product launches in OTC analgesics, % share by claim, Europe, Jan 2010-May 2011

The Consumer


Figure 3: Ailments suffered and use of pain relief, France, Germany, GB and Spain, 2010

Nearly eight in ten European adults wait until they feel really ill before seeing their GP


Figure 4: Sources of information, advice or diagnosis, France, Germany, GB and Spain, 2010

Figure 5: Most frequent visitors to the GP (ie going once a month or more), by gender and country, 2010

Figure 6: Source of purchasing non-prescription pharmaceuticals and chemists products, France, Germany, GB and Spain, 2010

European Market Size and Forecast


Key points


OTC pharmaceuticals


Figure 7: Value sales of OTC pharmaceuticals* in current terms, €/£ million, France, Germany, Italy, Spain and UK, 2008-10

OTC analgesics


Figure 8: Value sales of OTC analgesics in current terms, France, Germany, Italy, Spain and UK, €/£ million, 2005-15

France


Germany


Italy


Spain


UK


Other Europe


Figure 9: Value sales of OTC pharmaceuticals* in current terms, other European countries, 2008-10

OTC analgesics


Figure 10: Value sales of OTC analgesics in current terms, other European countries, 2005-14

OTC analgesics average spend per capita


Figure 11: OTC analgesics, spend per capita, 2005-15

Companies and Product Innovation


Key points


Figure 12: 7 New product activity in OTC analgesics, % share by global region, Jan 2010-May 2011

Figure 13: New product activity in OTC analgesics, Europe, % share by country, Jan 2010-May 2011

Product attributes


Figure 14: New product launches in OTC analgesics, % share by claim, Europe, Jan 2010-May 2011

UK


Figure 15: OTC analgesic launches, % share by claim, UK, Jan 2010-May 2011

Most innovative products

Germany


Figure 16: OTC analgesic launches, % share by claim, Germany, Jan 2010-May 2011

Most innovative products

France


Figure 17: OTC analgesic launches, % share by claim, France, Jan 2010-May 2011

Most innovative products

Italy


Figure 18: OTC analgesic launches, % share by claim, Italy, Jan 2010-May 2011

Most innovative products

Spain


Figure 19: OTC analgesic launches, % share by claim, Spain, Jan 2010-May 2011

Most innovative products

The Consumer – Ailments Suffered and Use of OTC Analgesics


Key points


Ailments suffered


Figure 20: Ailments suffered in last 12 months, France, Germany, GB and Spain, 2010

Headaches


Colds/flu


Back pain/arthritis/rheumatism


Headache remedies


Figure 21: Frequency of using headache remedies, France, Germany, GB and Spain, 2010

France


Figure 22: Usage of headache remedies by gender and age, France, 2010

Germany


Figure 23: Frequency of using headache remedies, by gender, Germany, 2010

Figure 24: Indexed volume usage of headache remedies, by gender and age, Germany, 2010

Spain


Figure 25: Usage of headache remedies, by gender, Spain, 2010

Figure 26: Usage of headache remedies, by gender, Spain, 2010

GB


Figure 27: Usage of headache remedies, by gender, GB, 2010

Muscular and joint pain remedies


Figure 28: Trends in frequency of using muscular and joint pain remedies, men by country, 2010

Figure 29: Trends in frequency and usage of muscular and joint pain remedies, women by country, 2010

Figure 30: types of muscular and joint pain remedies (for external use) used in the last 12 months, Germany and Spain, 2010

The Consumer – Attitudes Towards visiting GPs


Key points


Figure 31: Attitudes towards health, France, Germany, GB and Spain, 2010

Figure 32: Periodical check-ups, by age and country, 2010

Sources used for information, advice or diagnosis


Figure 33: Sources of information, advice or diagnosis, by country, 2010

Family doctors


Pharmacists


Alternative health practitioners


Books, newspapers, magazines, internet, TV and radio


Frequency of visiting GP


Figure 34: Frequency of visits to GP surgeries, men, by country, 2010

Figure 35: Trends in frequency of visits to GP surgeries, women, by country, 2010

The Consumer – Shopping for OTC medicines


Key points


Figure 36: Where non-prescription pharmaceuticals and chemists products are bought, France, Germany, GB and Spain, 2010

France


Germany


Spain


GB


Appendix – Ailments Suffered and Use of OTC Analgesics


Figure 37: Selected ailments suffered in the last 12 months, by demographics, France, 2010

Figure 38: Selected ailments suffered in the last 12 months, by demographics, France, 2010

Figure 39: Selected ailments suffered in the last 12 months, by demographics, Germany, 2010

Figure 40: Selected ailments suffered in the last 12 months, by demographics, Germany, 2010

Figure 41: Selected ailments suffered in the last 12 months, by demographics, Spain, 2010

Figure 42: Selected ailments suffered in the last 12 months, by demographics, Spain, 2010

Figure 43: Selected ailments suffered in the last 12 months, by demographics, GB, 2010

Figure 44: Selected ailments suffered in the last 12 months, by demographics, GB, 2010

Usage of headache remedies


Figure 45: Usage of headache remedies in the last 12 months, by demographics, France, 2010

Figure 46: Usage of headache remedies in the last 12 months, by demographics, Germany, 2010

Figure 47: Usage of headache remedies in the last 12 months, by demographics, Spain, 2010

Figure 48: Usage of headache remedies in the last 12 months, by demographics, GB, 2010

Appendix – Attitudes Towards Visiting GPs


Figure 49: Attitudes towards health, by demographics, France, 2010

Figure 50: Attitudes towards health, by demographics, France, 2010

Figure 51: Attitudes towards health, by demographics, Germany, 2010

Figure 52: Attitudes towards health, by demographics, Germany, 2010

Figure 53: Attitudes towards health by demographics, Spain, 2010

Figure 54: Attitudes towards health, by demographics, GB, 2010

Figure 55: Attitudes towards health, by demographics, GB, 2010

Figure 56: Frequency of visiting GP, by demographics, France, 2010

Figure 57: Frequency of visiting GP, by demographics, France, 2010

Germany


Figure 58: Frequency of visiting GP, by demographics, Germany, 2010

Figure 59: Frequency of visiting GP, by demographics, Germany, 2010

Spain


Figure 60: Frequency of visiting GP, by demographics, Spain, 2010

Figure 61: Frequency of visiting GP, by demographics, Spain, 2010

GB


Figure 62: Frequency of visiting GP, by demographics, GB, 2010

Figure 63: Frequency of visiting GP, by demographics, GB, 2010

Registered office :

Mintel Group Ltd.
11 Pilgrim Street, London, EC4V 6RN
Registered in England: Number 1475918.

Geolocation by www.maxmind.com